No change of serum levels of leptin and adiponectin during anti-tumour necrosis factor antibody treatment with adalimumab in patients with rheumatoid arthritis

Ann Rheum Dis. 2006 Jul;65(7):970-1. doi: 10.1136/ard.2005.040857.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adalimumab
  • Adiponectin / blood*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Arthritis, Rheumatoid / blood*
  • Arthritis, Rheumatoid / drug therapy
  • Arthritis, Rheumatoid / immunology
  • Female
  • Humans
  • Leptin / blood*
  • Male
  • Middle Aged
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Adiponectin
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Leptin
  • Tumor Necrosis Factor-alpha
  • Adalimumab